Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 9.5B | 8.5B | 9.3B | 8.5B |
Cost of revenue | 5.9B | 5.2B | 5.8B | 5.4B |
Gross profit | 3.6B | 3.4B | 3.5B | 3.1B |
Operating expense | ||||
Research & development | 308.7M | 308.7M | 331.1M | 284.6M |
Selling general and admin | 1.5B | 1.4B | 910.6M | 1.8B |
Other operating expenses | — | — | — | — |
Operating income | 1.8B | 1.7B | 2.2B | 1.1B |
Non operating interest income | ||||
Income | 137.6M | 148.8M | 169.4M | 160.8M |
Expense | 135.9M | 180.6M | 192.6M | 215.8M |
Other income expense | 246.8M | 239.9M | -246.8M | 616.5M |
Pretax income | 2.1B | 1.9B | 2.0B | 1.6B |
Tax provision | 333.6M | 243.4M | 339.7M | 170.3M |
Net income | 1.7B | 1.7B | 1.6B | 1.6B |
Basic EPS | 1.9 | 1.9 | 1.8 | 1.7 |
Diluted EPS | 1.9 | 1.8 | 1.8 | 1.7 |
Basic average shares | 913.0M | 920.1M | 927.8M | 939.9M |
Diluted average shares | 922.7M | 927.0M | 933.1M | 944.2M |
EBITDA | 2.5B | 2.4B | 3.0B | 1.8B |
Net income from continuing op. | 1.7B | 1.7B | 1.6B | 1.5B |
Minority interests | 6.0M | 4.3M | 6.0M | 8.6M |
Preferred stock dividends | — | — | — | — |